CLAG-Based Induction Therapy in Previously Untreated High Risk Acute Myeloid Leukemia Patients
Highlights • 20 previously untreated AML patients were treated with CLAG based induction therapy. • The CR rate was 65% after one cycle and 80% after two cycles of therapy. • The mean duration of response is 36.8 months and the median overall survival is 29.0 months. • Patients with de novo AML had...
Saved in:
Published in | Leukemia research Vol. 46; pp. 74 - 78 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.07.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • 20 previously untreated AML patients were treated with CLAG based induction therapy. • The CR rate was 65% after one cycle and 80% after two cycles of therapy. • The mean duration of response is 36.8 months and the median overall survival is 29.0 months. • Patients with de novo AML had a 90.9% response to induction therapy and a median overall survival of 38.5 months. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0145-2126 1873-5835 |
DOI: | 10.1016/j.leukres.2016.04.015 |